
Abstract:
Increasing the complexity of in vitro cell cultures to better model the in vivo environment is a growing focus in drug discovery and mechanistic research.
It is well established that cells cultured in three-dimensional (3D) structures respond differently to compounds compared to those grown in traditional two-dimensional (2D) monocultures. However, in vivo, cells do not grow in isolation. For example, cancer tissues contain regions with fibroblasts and various immune cells, all of which interact and can influence patient outcomes upon treatment.
This presentation will discuss the approach used at Concept Life Sciences, with a particular focus on how we assess different cell types within co-cultures. Emphasis will be placed on the inclusion of fibroblasts and immune cells, and how their interaction can influence outcomes.
Learning Objectives:
Dr. Darryl Turner | Principal Scientist | Concept Life Sciences

Since 2015, Dr. Darryl Turner has been an integral part of the immunology team at Aquila Biomedical, now Concept Life Sciences. He has led the development of custom assays in autoimmunity and immuno-oncology and his work emphasizes pioneering 3D cell culture methodologies to improve the translational relevance of immunological research.
He earned his PhD in Veterinary Parasitology and Immunology from Napier University Edinburgh in 2008, in collaboration with the Moredun Research Institute. Following his doctorate, he conducted four years of postdoctoral research at Moredun. In 2012, Dr. Turner joined the University of Edinburgh, where he studied regulatory T cell function and polarization in autoimmune disease within Professor Steve Anderton’s group.